Nucleix Company
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.
Technology:
Biomarker Pannel
Industry:
Longevity Biomarkers
Headquarters:
Rehovot, HaMerkaz, Israel
Founded Date:
2008-01-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
13
Total Funding:
82986064
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-01-05
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership